Chinese Expert Consensus on the Diagnosis and Treatment of Castration-Resistant Prostate Cancer (2019 Update)

Currently, the basic treatment of advanced prostate cancer is still endocrine therapy, but almost all patients eventually progress to castration-resistant prostate cancer (CRPC). In 2016, the Chinese Expert Consensus on the Diagnosis and Treatment of CRPC which aimed to help Chinese clinicians formu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yao, Ye, Dingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103027/
https://www.ncbi.nlm.nih.gov/pubmed/32273753
http://dx.doi.org/10.2147/CMAR.S236879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103027/
https://www.ncbi.nlm.nih.gov/pubmed/32273753
http://dx.doi.org/10.2147/CMAR.S236879

Ejemplares similares